Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2022-04-04 Major Shareholding Noti…
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is very short (296 characters) and contains a tabular disclosure under Regulation 31(4) related to shareholding or promoter information for the financial year ending 31-Mar-2022. This matches the description of a Major Shareholding Notification, which reports changes or disclosures of significant share ownership levels. There is no indication of a full report or financial statements, nor is it an announcement of a report publication. Therefore, the document fits best under Major Shareholding Notification (MRQ).
2022-04-04 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is very short (296 characters) and contains a tabular disclosure under Regulation 31(4), which relates to shareholding or promoter disclosures. It lists company names, category, and financial year end but does not contain financial statements or detailed report content. This fits the description of a Major Shareholding Notification rather than a full report or announcement of a report. Therefore, the appropriate classification is MRQ (Major Shareholding Notification).
2022-04-04 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document text is extremely short (127 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report content, or detailed information. Given the lack of content, this document cannot be classified as a full report or detailed filing. It fits the criteria for a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2022-03-31 English
Communication to shareholders as per Reg 30
Regulatory Filings
2022-03-30 English
Communication to shareholders as per Reg 30
Regulatory Filings
2022-03-24 English
Communication to shareholders as per Reg 30
Regulatory Filings Classification · 100% confidence The document text contains no substantive content, only placeholders for omitted pictures and no textual information. The true document length is only 129 characters, indicating it is extremely short and contains no report or announcement details. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as any specific report or announcement and defaults to the fallback category for miscellaneous filings.
2022-03-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.